Biocryst Pharmaceuticals Inc (BCRX)
Equity Ratio
-81.44%
Quarterly · Period ending:
BCRX Equity Ratio
Latest reported-81.44%period ending
Latest reported-81.44%period ending
BCRX Quarterly Equity Ratio (85.38% → -81.44%)
Latest values, visible window
High-resolution chart · PNG
BCRX equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| -81.4355% | |
| -119.0927% | |
| -23.1744% | |
| -86.888% | |
| -92.2146% | |
| -94.1422% | |
| -97.0462% | |
| -95.381% | |
| -100.6746% | |
| -101.7686% | |
| -88.1167% | |
| -78.5938% | |
| -73.358% | |
| -64.4032% | |
| -53.5631% | |
| -43.441% | |
| -41.7661% | |
| -31.1178% | |
| -18.1902% | |
| -55.329% | |
| -38.255% | |
| -26.3642% | |
| -5.7547% | |
| 19.0874% | |
| 35.6334% | |
| 2.6708% | |
| 21.8231% | |
| -45.5834% | |
| -7.9016% | |
| 15.8124% | |
| 33.5295% | |
| 43.2974% | |
| 33.7988% | |
| 39.939% | |
| 46.9917% | |
| 52.5515% | |
| 21.2107% | |
| 29.7499% | |
| 1.7563% | |
| 4.3638% | |
| 16.2825% | |
| 27.0196% | |
| 38.3156% | |
| 46.0901% | |
| 50.6649% | |
| 49.5669% | |
| 55.2589% | |
| 60.8598% | |
| 63.4541% | |
| -13.1906% | |
| -2.3043% | |
| 6.4092% | |
| -22.6651% | |
| -6.0556% | |
| -0.7904% | |
| 15.2651% | |
| 20.5402% | |
| 28.9068% | |
| 18.0104% | |
| 28.1502% | |
| 36.2192% | |
| 44.1238% | |
| 59.8491% | |
| 66.7681% | |
| 72.0119% | |
| 68.611% | |
| 60.6695% | |
| 38.8608% | |
| 48.3584% | |
| 53.0523% | |
| 54.8179% | |
| 35.2367% | |
| 39.4086% | |
| 41.9865% | |
| 45.4782% | |
| 46.4804% | |
| 11.9131% | |
| 20.6034% | |
| 30.8898% | |
| 37.4348% | |
| 48.3168% | |
| 52.0621% | |
| 58.883% | |
| 90.179% | |
| 94.1025% | |
| 93.9724% | |
| 90.3465% | |
| 90.582% | |
| 94.3541% | |
| 94.5053% | |
| 94.5209% | |
| 95.5613% | |
| 95.5652% | |
| 96.9219% | |
| 97.1609% | |
| 97.2013% | |
| 96.5223% | |
| 96.5489% | |
| 96.1375% | |
| 98.2497% |